NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









MiRus

MiRus

Private
Marietta, GeorgiaHealthcare & Life Scienceshttps://www.mirusmed.com/

Last Round

Corporate Funding

May 15, 2026

Est. Valuation

$4.44B

Total Funding Raised

$1.57B

Momentum

Quiet

No recent growth signals

Company Overview

MiRus is a medical technology company that develops and commercializes proprietary biomaterials, implants, and procedural solutions for the treatment of spinal, orthopedic, and cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

medical devicestranscatheter aortic valve replacementTAVRspine implantsbiocompatible materialssurgical implantsmedtechMoRe alloysurgical planningstructural heartorthopedic hardwareclinical decision supportsurgical navigation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MiRus Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MiRus Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMay 15, 2026
Series DJul 27, 2021

Key People

Founding team and executive leadership

Jay Yadav

Founder And CEO

Founding Team

David Toney

Chief Financial Officer

Executive Team

Noah M. Roth

COO At MiRus, LLC

Executive Team

MiRus Investors

Notable investors and investment history

InvestorRounds
Mammoth ScientificSeries C, Series B, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2025

    Pivotal trial for TAVR system underway, targeting FDA/EMA submissions.

MiRus Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MiRus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MiRus's valuation, stock price, and market status.

Firmographic Details

HeadquartersMarietta, Georgia
Employee Range136
Year Founded2016
Last FundingMay 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.